The FDA and the Next Wave of Drug Abuse In responding to the opioid crisis, the FDA needs to recognize shifting trends in the addiction landscape. Taking a systematic approach to monitoring such trends should allow the agency to intervene promptly and appropriately to protect the public from associated risks.
No takes yet. Share an insight, caveat, or question.
Throckmorton et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: